Gulf International Bank UK Ltd raised its stake in Becton Dickinson and Co. (NYSE:BDX) by 0.6% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 65,407 shares of the company’s stock after buying an additional 400 shares during the period. Gulf International Bank UK Ltd’s holdings in Becton Dickinson and were worth $11,755,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also modified their holdings of the company. Point72 Asia Hong Kong Ltd purchased a new position in Becton Dickinson and during the second quarter valued at about $119,000. Acrospire Investment Management LLC increased its position in Becton Dickinson and by 458.0% in the second quarter. Acrospire Investment Management LLC now owns 731 shares of the company’s stock valued at $124,000 after buying an additional 600 shares in the last quarter. Iowa State Bank purchased a new position in Becton Dickinson and during the second quarter valued at about $137,000. First Personal Financial Services increased its position in Becton Dickinson and by 101.7% in the second quarter. First Personal Financial Services now owns 827 shares of the company’s stock valued at $140,000 after buying an additional 417 shares in the last quarter. Finally, First PREMIER Bank increased its position in Becton Dickinson and by 251.0% in the third quarter. First PREMIER Bank now owns 839 shares of the company’s stock valued at $151,000 after buying an additional 600 shares in the last quarter. 81.35% of the stock is owned by hedge funds and other institutional investors.

Institutional Ownership by Quarter for Becton Dickinson and (NYSE:BDX)

Shares of Becton Dickinson and Co. (NYSE:BDX) traded down 1.99% during trading on Wednesday, reaching $169.30. The company’s stock had a trading volume of 586,259 shares. Becton Dickinson and Co. has a one year low of $129.50 and a one year high of $181.76. The stock’s 50 day moving average is $171.40 and its 200 day moving average is $172.45. The firm has a market cap of $35.95 billion, a P/E ratio of 37.71 and a beta of 1.04.

Becton Dickinson and (NYSE:BDX) last issued its quarterly earnings results on Thursday, November 3rd. The company reported $2.12 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $2.09 by $0.03. The company had revenue of $3.23 billion for the quarter, compared to analysts’ expectations of $3.22 billion. Becton Dickinson and had a return on equity of 24.45% and a net margin of 7.82%. The firm’s revenue for the quarter was up 5.6% on a year-over-year basis. During the same period in the prior year, the firm earned $1.94 earnings per share. On average, equities analysts forecast that Becton Dickinson and Co. will post $9.52 EPS for the current fiscal year.

The company also recently declared a quarterly dividend, which will be paid on Friday, December 30th. Investors of record on Friday, December 9th will be paid a $0.73 dividend. This represents a $2.92 annualized dividend and a yield of 1.69%. This is a boost from Becton Dickinson and’s previous quarterly dividend of $0.66. The ex-dividend date is Wednesday, December 7th. Becton Dickinson and’s dividend payout ratio is presently 58.54%.

TRADEMARK VIOLATION NOTICE: “Becton Dickinson and Co. (BDX) Position Raised by Gulf International Bank UK Ltd” was published by Financial Market News and is the propert of of Financial Market News. If you are reading this piece on another domain, it was illegally copied and reposted in violation of US & international copyright legislation. The correct version of this piece can be read at http://www.financial-market-news.com/becton-dickinson-and-co-bdx-position-raised-by-gulf-international-bank-uk-ltd/1210832/.

A number of research firms have weighed in on BDX. Citigroup Inc. downgraded shares of Becton Dickinson and from a “neutral” rating to a “sell” rating and decreased their target price for the company from $167.00 to $165.00 in a research report on Friday, September 23rd. Zacks Investment Research raised shares of Becton Dickinson and from a “hold” rating to a “buy” rating and set a $200.00 target price for the company in a research report on Wednesday, November 9th. Deutsche Bank AG reissued a “buy” rating and set a $189.00 target price (down previously from $197.00) on shares of Becton Dickinson and in a research report on Friday, November 4th. Cowen and Company reissued an “outperform” rating and set a $185.00 target price on shares of Becton Dickinson and in a research report on Tuesday, August 16th. Finally, Jefferies Group reissued a “buy” rating on shares of Becton Dickinson and in a research report on Friday, August 5th. One analyst has rated the stock with a sell rating, six have issued a hold rating, seven have issued a buy rating and two have issued a strong buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and a consensus target price of $175.65.

In related news, insider Linda M. Tharby sold 11,704 shares of the company’s stock in a transaction on Tuesday, September 6th. The stock was sold at an average price of $177.27, for a total value of $2,074,768.08. Following the sale, the insider now directly owns 22,146 shares of the company’s stock, valued at $3,925,821.42. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, insider Stephen Sichak sold 10,352 shares of the company’s stock in a transaction on Friday, November 4th. The stock was sold at an average price of $176.10, for a total value of $1,822,987.20. Following the completion of the sale, the insider now directly owns 26,892 shares in the company, valued at $4,735,681.20. The disclosure for this sale can be found here. 1.60% of the stock is owned by corporate insiders.

About Becton Dickinson and

Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical devices, instrument systems and reagents used by healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public.

5 Day Chart for NYSE:BDX

Want to see what other hedge funds are holding BDX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Becton Dickinson and Co. (NYSE:BDX).

Receive News & Ratings for Becton Dickinson and Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Becton Dickinson and Co. and related companies with MarketBeat.com's FREE daily email newsletter.